AGT and triple-A syndrome: Infusion of AngII at the dose of either 500 or 1000 ng/kg/min for 28 days showed an AAA incidence of 30–40% or 60–80%, respectively, in male hypercholesterolemic mice, whereas it showed 0–10% of AAA incidence in female mice [4,5].